MGK: " The truth about the trials we performed needs to get out there. The data is clean and validated and speaks volumes about leronlimab's capacity, but it is hardly known where it needs to be known. Word about this CCR5 blockade needs to get out. Not just the generalized CCR5 blockade capacities, but rather, this specific CCR5 blockade, leronlimab, needs to be known. It has to be understood why this one is different. Why it passes where others fail. That it is safe, where others have black box warnings. Remember, we are now a sprouting seed, that is moving towards seedling. So shine the light Dr. Lalezari."

IMUO this is why the Chinese chose a neer do well drug to plum the CCR/CCL axis. They did not know about LL due to lack of Journal coverage

https://www.sciencedirect.com/science/article...3524000296